228 related articles for article (PubMed ID: 3499513)
21. Human histocompatibility leukocyte antigen (HLA) haplotype frequencies estimated from the data on HLA class I, II, and III antigens in 111 Japanese narcoleptics.
Matsuki K; Juji T; Tokunaga K; Naohara T; Satake M; Honda Y
J Clin Invest; 1985 Dec; 76(6):2078-83. PubMed ID: 3865934
[TBL] [Abstract][Full Text] [Related]
22. A molecular and serologic analysis of the major histocompatibility complex and complement component C4 in systemic sclerosis.
Briggs D; Stephens C; Vaughan R; Welsh K; Black C
Arthritis Rheum; 1993 Jul; 36(7):943-54. PubMed ID: 8318041
[TBL] [Abstract][Full Text] [Related]
23. Extended major histocompatibility complex haplotypes in celiac patients in the west of Ireland.
Mannion A; Stevens FM; McCarthy CF; Grimes-O'Cearbhaill H; Killeen AA
Am J Med Genet; 1993 Feb; 45(3):373-7. PubMed ID: 8434627
[TBL] [Abstract][Full Text] [Related]
24. HLA-DR antigens in progressive systemic sclerosis (scleroderma).
Whiteside TL; Medsger TA; Rodnan GP
J Rheumatol; 1983 Feb; 10(1):128-31. PubMed ID: 6601709
[TBL] [Abstract][Full Text] [Related]
25. C4A and C4B null alleles are genetic markers of different types of systemic sclerosis in Japanese patients.
Takeuchi F; Nabeta H; Hong GH; Matsuta K; Tokunaga K; Tanimoto K; Nakano K
Clin Exp Rheumatol; 1998; 16(1):55-60. PubMed ID: 9543562
[TBL] [Abstract][Full Text] [Related]
26. Scleroderma: DR antigens, autoantibodies and clinical manifestations.
Alarcón GS; McCarty GA; Lanyon P; Phillips RM; Acton RT; Barger BO
Clin Exp Rheumatol; 1987; 5(4):317-21. PubMed ID: 3326691
[TBL] [Abstract][Full Text] [Related]
27. HLA antigens, autoantibodies and clinical subsets in scleroderma.
Black CM; Welsh KI; Maddison PJ; Jayson MI; Bernstein RM
Br J Rheumatol; 1984 Nov; 23(4):267-71. PubMed ID: 6593111
[TBL] [Abstract][Full Text] [Related]
28. Pedigree of the major histocompatibility complex in a family with a neonatal alloimmune thrombocytopenia.
Panzer S; Kiefel V; Mayr WR; Fielder AH; Lachmann D; Mueller-Eckhardt C
Biol Neonate; 1987; 51(4):194-7. PubMed ID: 3472608
[TBL] [Abstract][Full Text] [Related]
29. Genetic and environmental factors in systemic sclerosis.
Fox RI; Kang HI
Curr Opin Rheumatol; 1992 Dec; 4(6):857-61. PubMed ID: 1457281
[TBL] [Abstract][Full Text] [Related]
30. Familial CREST syndrome.
McColl GJ; Buchanan RR
J Rheumatol; 1994 Apr; 21(4):754-6. PubMed ID: 8035406
[TBL] [Abstract][Full Text] [Related]
31. Polymorphism of the fourth component of complement in Graves' disease and type I diabetes mellitus.
Skanes V; Larsen B; Sampson-Murphy L; Farid NR
Clin Invest Med; 1985; 8(2):126-32. PubMed ID: 3869086
[TBL] [Abstract][Full Text] [Related]
32. Immunogenetic markers as prognostic features in patients from Kentucky with IgA nephropathy.
Wyatt RJ; Julian BA; Woodford SY; McLean RH; Thompson JS
Semin Nephrol; 1987 Dec; 7(4):389-92. PubMed ID: 3502194
[No Abstract] [Full Text] [Related]
33. Complement system protein C4 and susceptibility to hydralazine-induced systemic lupus erythematosus.
Speirs C; Fielder AH; Chapel H; Davey NJ; Batchelor JR
Lancet; 1989 Apr; 1(8644):922-4. PubMed ID: 2565418
[TBL] [Abstract][Full Text] [Related]
34. HLA and autoimmunity in scleroderma (systemic sclerosis).
Arnett FC
Int Rev Immunol; 1995; 12(2-4):107-28. PubMed ID: 7650416
[TBL] [Abstract][Full Text] [Related]
35. Complete deficiencies of complement C4A and C4B including 2-bp insertion in codon 1213 are genetic risk factors of systemic lupus erythematosus in Thai populations.
Ittiprasert W; Kantachuvesiri S; Pavasuthipaisit K; Verasertniyom O; Chaomthum L; Totemchokchyakarn K; Kitiyanant Y
J Autoimmun; 2005 Aug; 25(1):77-84. PubMed ID: 15998580
[TBL] [Abstract][Full Text] [Related]
36. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex.
Chao MJ; Ramagopalan SV; Herrera BM; Lincoln MR; Dyment DA; Sadovnick AD; Ebers GC
Hum Mol Genet; 2009 Jan; 18(2):261-6. PubMed ID: 19098025
[TBL] [Abstract][Full Text] [Related]
37. Association of HLA-DR5 (DR11) with systemic sclerosis (scleroderma) in Mexican patients.
Vargas-Alarcón G; Granados J; Ibañez de Kasep G; Alcocer-Varela J; Alarcón-Segovia D
Clin Exp Rheumatol; 1995; 13(1):11-6. PubMed ID: 7774089
[TBL] [Abstract][Full Text] [Related]
38. Histocompatibility antigens in progressive systemic sclerosis (scleroderma).
Birnbaum NS; Rodnan GP; Rabin BS; Bassion S
J Rheumatol; 1977; 4(4):425-8. PubMed ID: 604479
[TBL] [Abstract][Full Text] [Related]
39. [Complement markers Bf and C4 in multiple sclerosis].
Fauchet R; Madigand M; Gueguen-Duchesne MY; Papin J; Sabouraud O; Genetet B
Rev Neurol (Paris); 1984; 140(6-7):422-5. PubMed ID: 6611572
[TBL] [Abstract][Full Text] [Related]
40. HLA, C4, Bf, Gm and autoantibodies in rheumatoid arthritis.
Warlow RS; Uko G; Feeney DJ; Kay PH
Exp Clin Immunogenet; 1988; 5(2-3):133-42. PubMed ID: 3272816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
